News & media
Here you can find our news and media resources. To comply with applicable regulation in Denmark, press releases and company announcements concerning specific medicinal products or investigational candidates in late-stage development are removed from our website within three weeks of publication. Please contact us to request a copy.
-
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
-
Steven R. Smith, MD, joins Zealand Pharma as Senior Global Medical Advisor in Obesity
-
Zealand Pharma to present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13th
-
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
-
Zealand Pharma major shareholder announcement: The Capital Group Companies, Inc.
-
U.S. Food and Drug Administration issues Complete Response Letter for the glepaglutide New Drug Application for the treatment of short bowel syndrome
-
Zealand Pharma announces first participant enrolled in Phase 2b ZUPREME-1 trial of petrelintide in people with overweight or obesity
-
Zealand Pharma to participate in the Jefferies London Healthcare Conference
-
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
-
Zealand Pharma Announces Financial Results for the First Nine Months of 2024
-
Zealand Pharma conference call on November 7 at 2pm CET (8am ET) to present third quarter 2024 financial results
-
Zealand Pharma provides U.S. regulatory update on dasiglucagon in congenital hyperinsulinism
Corporate management
-
Adam Steensberg - President and Chief Executive Officer
-
Adam Steensberg - President and Chief Executive Officer
-
Adam Steensberg - President and Chief Executive Officer
-
Henriette Wennicke - Executive Vice President and Chief Financial Officer
-
Christina Sonnenborg Bredal - Executive Vice President and Chief People Officer
-
David Kendall - Executive Vice President, Research & Development and Chief Medical Officer
-
Ivan Møller - Executive Vice President and Chief Operating Officer
-
Utpal Singh - Executive Vice President and Chief Scientific Officer
-
Utpal Singh - Executive Vice President and Chief Scientific Officer
Research and development
-
Lab photo
-
Lab photo
-
Lab photo
-
Lab photo
-
Lab photo
-
Lab photo
-
Lab photo
Sustainability
-
Morten Lagstrøm - ESG Officer
Logos and icons
-
)
Zealand Pharma Logo (RGB)
Stay up-to-date with the latest news from Zealand
Sign-up to receive press releases and company announcements directly to your inbox
Investor and Media contacts
